IN8BIO, INC. 8-K

What Happened
On March 12, 2026, IN8bio, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025, via a press release. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02). The Form 8‑K notes the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not automatically incorporated by reference into other filings. The report was signed by Patrick McCall, Chief Financial Officer and Secretary.

Key Details

• Date of filing: March 12, 2026 (Form 8‑K).
• Period reported: Fourth quarter and fiscal year ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Form 8‑K.
• Disclosure clarifies the press release is furnished (not “filed”) and includes the standard Section 18 limitation.

Why It Matters
The company has publicly released its quarterly and full-year financial results; investors should review the Exhibit 99.1 press release for specific metrics (revenue, earnings/loss, cash position, guidance, or operational updates). Note that because the release is furnished rather than filed, it carries different legal treatment under the Exchange Act and won’t be automatically incorporated into other SEC filings unless expressly referenced. Check the press release and subsequent SEC filings (e.g., 10‑K) for full numeric detail and context before making investment decisions.